Mesoblast (MESO) Net Income towards Common Stockholders (2015 - 2025)

Mesoblast has disclosed Net Income towards Common Stockholders across 11 years of filings, most recently posting -$40.2 million for Q4 2025.

• Net Income towards Common Stockholders for Q4 2025 came in at -$40.2 million, up 16.21% year-over-year; the trailing twelve-month figure through Dec 2025 was -$168.6 million (down 9.19% YoY), and the FY2025 annual result was -$102.1 million, down 16.13% from the prior year.
• Net Income towards Common Stockholders came in at -$40.2 million for Q4 2025 at Mesoblast, up from -$47.9 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $26.5 million in Q1 2021 to a low of -$76.8 million in Q2 2021.
• The 5-year median for Net Income towards Common Stockholders is -$32.5 million (2023), against an average of -$26.0 million.
• Across the five-year window, Net Income towards Common Stockholders soared 73.72% in 2021 and plunged 381.52% in 2023, its largest moves.
• Mesoblast's Net Income towards Common Stockholders stood at $25.9 million in 2021, then fell by 5.62% to $24.5 million in 2022, then sank by 232.89% to -$32.5 million in 2023, then sank by 47.31% to -$47.9 million in 2024, then grew by 16.21% to -$40.2 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$40.2 million (Q4 2025), -$47.9 million (Q2 2025), and -$47.9 million (Q4 2024), per Business Quant data.